sutures newsletter


Melmed and Wallace Honored by Los Angeles County Medical Association

Shlomo Melmed, MD

Daniel J. Wallace, MD

Shlomo Melmed, MB, ChB, executive vice president, Academic Affairs, and dean of the Cedars-Sinai medical faculty, and Daniel J. Wallace, MD, FACP, associate director of the Cedars-Sinai Rheumatology Fellowship Program, will be honored by the Los Angeles County Medical Association (LACMA) at its Los Angeles Healthcare Awards Dinner Nov. 1 in Beverly Hills. The annual event recognizes individuals and institutions for exemplary contributions to improving healthcare in Los Angeles County.

Melmed, professor of Medicine and the Helene A. and Philip E. Hixon Distinguished Chair in Investigative Medicine, will receive the 2017 Hospital Physician Leadership Award. An internationally recognized authority on pituitary medicine, Melmed has helmed landmark studies uncovering mechanisms of pituitary tumor development and identified novel molecules as therapeutic targets. Over the course of his career, he has trained more than 70 physicians, scientists and graduate students who now occupy leading positions in academic endocrinology worldwide.

"Dr. Melmed has led the spectacular growth of world-class Cedars-Sinai programs in heart disease, cancer, regenerative medicine, neurosciences, surgical specialties, gastroenterology, transplantation, women’s health, metabolic and pulmonary disorders, as well as founding the Cedars-Sinai Graduate Program," said Troy Elander, MD, chair of the LACMA Patient Care Foundation. “These efforts have established Cedars-Sinai in the top echelons of America's academic medical centers."

"I am humbled by this award and consider it an affirmation of Cedar-Sinai's leadership position in delivering quality healthcare, expanding medical knowledge through research and training the next generation of physician-scientists," Melmed said.

Wallace, a professor in the Cedars-Sinai Department of Medicine, will receive the 2017 Innovation Award for Community Service. For nearly 40 years, Wallace has been practicing clinical rheumatology with a focus on systemic lupus erythematosus (SLE). His office currently manages the care of some 1,500 SLE patients, which is among the largest practices of its kind nationwide. A highly accomplished investigator, Wallace opened one of the first clinical trial centers for developing targeted rheumatoid arthritis and lupus therapies, and is credited with discovering a new autoantibody that could prove pivotal in relation to SLE and accelerated aging.

Commenting on the award, Elander praised Wallace for being "our nation's most highly regarded physician in the care and treatment of patients diagnosed with lupus." He also applauded Wallace's founding of Lupus LA, a nonprofit organization that has raised more than $10 million for funding medical research, rheumatology fellowships and support services for lupus patients and their families throughout greater Los Angeles.

"This award is a tribute to the decades-long opportunity the Cedars-Sinai Department of Medicine and Division of Rheumatology have given me to try and make a difference in patients' lives," Wallace said.

Founded in 1871, LACMA is a professional organization representing more than 6,000 physicians.